E-mail a Wiley Online Library Link

Christine Chevreau, Axel Le Cesne, Isabelle Ray-Coquard, Antoine Italiano, Angela Cioffi, Nicolas Isambert, Yves Marie Robin, Charles Fournier, Stéphanie Clisant, Loic Chaigneau, Jacques-Olivier Bay, Emmanuelle Bompas, Eric Gauthier, Jean Y. Blay and Nicolas Penel Sorafenib in patients with progressive epithelioid hemangioendothelioma Cancer 119

Version of Record online: 15 APR 2013 | DOI: 10.1002/cncr.28109

The authors report on a phase 2 trial investigating sorafenib as treatment for progressive epithelioid hemangioendothelioma. Two partial responses (in 2 of 15 patients) are observed, and the 9-month progression-free rate is 38.4% (4 of 13 patients).

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field